Mersana Therapeutics Inc (MRSN) — Financial Flexibility Index
Mersana Therapeutics Inc (MRSN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-3.19 Million (operating CF $-3.19 Million minus capex $0.00) represents 0% of total liabilities ($122.22 Million). Also explore Mersana Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mersana Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Mersana Therapeutics Inc across 10 annual periods. Check asset allocation strategy of Mersana Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mersana Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Mersana Therapeutics Inc. For the full company profile including market capitalisation, see market value of Mersana Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.53x | $-82.21 Million | $-82.34 Million | $154.17 Million | ▲ +39.5% |
| 2023 | -0.88x | $-166.71 Million | $-168.88 Million | $189.16 Million | ▼ -352.7% |
| 2022 | -0.19x | $-47.17 Million | $-49.36 Million | $242.28 Million | ▲ +88.2% |
| 2021 | -1.65x | $-139.34 Million | $-139.99 Million | $84.37 Million | ▼ -0.8% |
| 2020 | -1.64x | $-74.22 Million | $-74.70 Million | $45.31 Million | ▲ +28.7% |
| 2019 | -2.30x | $-67.14 Million | $-67.74 Million | $29.22 Million | ▼ -197.4% |
| 2018 | -0.77x | $-53.85 Million | $-55.22 Million | $69.71 Million | ▼ -12.9% |
| 2017 | -0.68x | $-41.54 Million | $-42.68 Million | $60.72 Million | ▼ -436.5% |
| 2016 | 0.20x | $32.67 Million | $31.59 Million | $160.71 Million | ▲ +228.7% |
| 2015 | -0.16x | $-9.02 Million | $-9.64 Million | $57.10 Million | — |